Final answer:
The DTaP vaccine, containing an acellular pertussis component, is used for children to protect against Bordetella pertussis, the causative agent of whooping cough, while the Tdap vaccine is a booster shot for older children and adults.
Step-by-step explanation:
The vaccine that contains the vaccine for Bordetella pertussis, which is the causative agent of whooping cough, is known as the Diphtheria, tetanus, and acellular pertussis (DTaP) vaccine. Another version of this vaccine for older children and adults is the tetanus, diphtheria, and acellular pertussis (Tdap) vaccine.
These vaccines use an acellular version of the pertussis component, indicated by the lowercase "aP," which contains a purified component of B. pertussis (pertussis toxoid) rather than the whole cell used in previous vaccines, such as the DPT vaccine.
The DTaP vaccine is recommended in a series of five doses for children at 2, 4, 6, and 15-18 months of age, and another dose at 4-6 years of age. Adolescents and adults should receive the Tdap vaccine as a booster shot.
The vaccine that contains the vaccine for Bordetella pertussis is called DtaP.